Bandingkan Harga & Kinerja H.M. Sampoerna Tbk. (HMSP) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan H.M. Sampoerna Tbk. dan Organon Pharma Indonesia Tbk.: H.M. Sampoerna Tbk. diperdagangkan di Rp730 (kapitalisasi pasar 86,08 T, volume 24 jam 6,17 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: H.M. Sampoerna Tbk. jauh lebih besar — sekitar 824,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| HMSP | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 86,08 T | 104,4 M |
Volume | 6,17 jt | — |
Lot | 61,7 rb | — |
Perputaran | 4,52 M | — |
Harga Rata-rata | 732,19 | — |
Nilai Transaksi | 4,52 M | — |
Harga Ekuilibrium Indikatif | 730 | — |
Volume Ekuilibrium Indikatif | 3,68 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang H.M. Sampoerna Tbk.
PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.
Selengkapnya di halaman HMSP →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
